Symbol
| ZBTB7A
| contributors: mct/npt - updated : 20-12-2017
|
HGNC name
| zinc finger and BTB domain containing 7A
|
HGNC id
| 18078
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
aberrantly, in breast, lung, colon, prostate and bladder carcinomas | tumoral
| germinal mutation
|  
|  
|  
|
in acute myeloid leukaemia with t(8;21) translocation | tumoral
|  
|  
|  
| loss of function
|
loss-of-function mutation in ZBTB7A is a novel mechanism causing elevated glycolysis in human cancer, which carries important therapeutic implication | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| is a potential prognostic biomarker for breast cancer | Therapy target
| attractive therapeutic target for the treatment of many types of cancer |
| |
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
aberrantly, in breast, lung, colon, prostate and bladder carcinomas | tumoral
| germinal mutation
|  
|  
|  
|
in acute myeloid leukaemia with t(8;21) translocation | tumoral
|  
|  
|  
| loss of function
|
loss-of-function mutation in ZBTB7A is a novel mechanism causing elevated glycolysis in human cancer, which carries important therapeutic implication | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| is a potential prognostic biomarker for breast cancer | Therapy target
| attractive therapeutic target for the treatment of many types of cancer |
| |